Literature DB >> 16305365

ATP-containing immunoliposomes specific for cardiac myosin.

Wei Liang1, Tatyana Levchenko, Ban-An Khaw, Vladimir Torchilin.   

Abstract

The application of ATP-loaded liposomes has been shown effective against ischemic damage in several tissues. In this study, we have prepared ATP-containing liposomes capable of specific recognition of component (myosin) specific for ischemic myocardium. ATP-containing immunoliposomes specific towards cardiac myosin were obtained by the attachment of the monoclonal anti-cardiac myosin 2G4 antibody to the surface of ATP-containing PEGylated liposomes prepared by the freezing-thawing method. Since intracellular myosin is exposed only in the areas containing ischemically compromised cells with damaged plasmic membranes, such liposomes are expected to target these areas both in vitro and in vivo. The attachment of the antibody did not provoke their ATP release from the liposomes and only minimally influenced liposome size and size distribution. Liposome-attached anti-myosin 2G4 antibody preserved its specific activity; and anti-myosin antibody-bearing, ATP-loaded liposomes bound efficiently to the monolayer of myosin in ELISA. The preparation of myosin-specific ATP-loaded immunoliposomes represented an important step in the development of targeted delivery systems capable of providing energy support to ischemic myocardium in vivo.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16305365     DOI: 10.2174/1567201043480063

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  11 in total

1.  ATP-loaded liposomes effectively protect the myocardium in rabbits with an acute experimental myocardial infarction.

Authors:  Daya D Verma; William C Hartner; Tatayana S Levchenko; Eugene A Bernstein; Vladimir P Torchilin
Journal:  Pharm Res       Date:  2005-11-05       Impact factor: 4.200

2.  Direct observation of proton pumping by a eukaryotic P-type ATPase.

Authors:  Salome Veshaguri; Sune M Christensen; Gerdi C Kemmer; Garima Ghale; Mads P Møller; Christina Lohr; Andreas L Christensen; Bo H Justesen; Ida L Jørgensen; Jürgen Schiller; Nikos S Hatzakis; Michael Grabe; Thomas Günther Pomorski; Dimitrios Stamou
Journal:  Science       Date:  2016-03-25       Impact factor: 47.728

3.  Novel asparagine-derived lipid enhances distearoylphosphatidylcholine bilayer resistance to acidic conditions.

Authors:  Adelphe M Mfuh; Mathew P D Mahindaratne; Maritza V Quintero; Frederick J Lakner; Ande Bao; Beth A Goins; William T Phillips; George R Negrete
Journal:  Langmuir       Date:  2011-03-17       Impact factor: 3.882

4.  Intracellular ATP levels are a pivotal determinant of chemoresistance in colon cancer cells.

Authors:  Yunfei Zhou; Federico Tozzi; Jinyu Chen; Fan Fan; Ling Xia; Jinrong Wang; Guang Gao; Aijun Zhang; Xuefeng Xia; Heather Brasher; William Widger; Lee M Ellis; Zhang Weihua
Journal:  Cancer Res       Date:  2011-11-14       Impact factor: 12.701

5.  "SMART" drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriers.

Authors:  R M Sawant; J P Hurley; S Salmaso; A Kale; E Tolcheva; T S Levchenko; V P Torchilin
Journal:  Bioconjug Chem       Date:  2006 Jul-Aug       Impact factor: 4.774

Review 6.  Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.

Authors:  James W Yockman; Andrew Kastenmeier; Harold M Erickson; Jonathan G Brumbach; Matthew G Whitten; Aida Albanil; Dean Y Li; Sung Wan Kim; David A Bull
Journal:  J Control Release       Date:  2008-07-06       Impact factor: 9.776

7.  PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations.

Authors:  Xin Wang; Hua Huang; Liangke Zhang; Yan Bai; Huali Chen
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

8.  β-Arrestin1 mediates the endocytosis and functions of macrophage migration inhibitory factor.

Authors:  Lishi Xie; Xiaohang Qiao; Yanfang Wu; Jie Tang
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

9.  Exosomes Engineered to Express a Cardiomyocyte Binding Peptide Demonstrate Improved Cardiac Retention in Vivo.

Authors:  Kyle I Mentkowski; Jennifer K Lang
Journal:  Sci Rep       Date:  2019-07-11       Impact factor: 4.379

Review 10.  Gemcitabine-loaded liposomes: rationale, potentialities and future perspectives.

Authors:  Cinzia Federico; Valeria M Morittu; Domenico Britti; Elena Trapasso; Donato Cosco
Journal:  Int J Nanomedicine       Date:  2012-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.